EUVIMEDEUVIMED entdecken
Crossref

Rationally Engineering Pro‐Proteins and Membrane‐Penetrating α‑Helical Polypeptides for Genome Editing Toward Choroidal Neovascularization Treatment

Xun Liu, Ziyin Zhao, Wei Li, Mengyao Ren, Haoyu Zhang, Desheng Cao, Yehan Wang, He Yang, Yajie Li, Manhui Zhu, Laiqing Xie, Lichen Yin iD

Advanced Materials · 2025

DOI: 10.1002/adma.202412366 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Advanced Materials, 2025. Verfasst von Xun Liu und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Thoracic Surgery, The Second Affiliated Hospital of Soochow University, Suzhou, 215004, China. Hauptthemen laut MEDLINE: Choroidal Neovascularization, Gene Editing, Peptides, Protein Engineering. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 75 Literaturangaben. Gefördert von: Natural Science Foundation of Jiangsu Province, National Natural Science Foundation of China, Jiangsu Key Research and Development Plan.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Ribonucleoprotein (RNP)‐based CRISPR/Cas9 genome editing holds great potential for the treatment of choroidal neovascularization (CNV), which however, is challenged by the lack of efficient cytosolic protein delivery tools. Herein, reversibly‐phosphorylated pro‐proteins (P‐proteins) with conjugated adenosine triphosphate (ATP) tags are engineered and coupled with a membrane‐penetrating, guanidine‐enriched, α‐helical polypeptide ( L GP) to mediate robust and universal cytosolic delivery. L GP forms salt‐stable nanocomplexes (NCs) with P‐proteins via electrostatic interaction and salt bridging, and the helix‐assisted, strong membrane activities of L GP enabled efficient cellular internalization and endolysosomal escape of NCs. Therefore, this approach allows efficient cytosolic delivery of a wide range of protein cargoes and maintains their bioactivities due to endolysosomal acidity‐triggered traceless restoration of P‐proteins. Notably, intravitreally delivered L GP/P‐RNP NCs targeting hypoxia‐inducible factor‐1α (HIF‐1α) induce pronounced gene disruption to downregulate pro‐angiogenic factors and alleviate subretinal fibrosis, ultimately provoking robust therapeutic efficacy in CNV mice. Such a facile and versatile platform provides a powerful tool for cytosolic protein delivery and genome editing, and it holds promising potential for the treatment of CNV‐associated diseases, such as age‐related macular degeneration.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Choroidal NeovascularizationGene EditingPeptidesProtein EngineeringAnimalsHumansMiceHypoxia-Inducible Factor 1, alpha SubunitProtein Conformation, alpha-HelicalCRISPR-Cas SystemsRibonucleoproteins

Stichwörter der Autor:innen

choroidal neovascularizationcytosolic protein deliverygenome editingpro‐proteinα‐helical polypeptide

Substanzen

PeptidesHypoxia-Inducible Factor 1, alpha SubunitRibonucleoproteins

Autor:innen und Institutionen

  • Department of Thoracic Surgery, The Second Affiliated Hospital of Soochow University, Suzhou, 215004, China.
  • Institute of Functional Nano and Soft Materials (FUNSOM), Jiangsu Key Laboratory of Carbon-Based Functional Materials and Devices, Soochow University, Suzhou, 215123, China.
  • Department of Ophthalmology, Lixiang Eye Hospital of Soochow University, Suzhou, 215123, China.
  • Department of Ophthalmology, The Second Affiliated Hospital of Soochow University, Suzhou, 215004, China.

ORCID-Profile: Lichen Yin

Förderung

  • Natural Science Foundation of Jiangsu Province
  • National Natural Science Foundation of China
  • Jiangsu Key Research and Development Plan
  • Collaborative Innovation Center of Suzhou Nano Science & Technology
  • 111 project
  • Joint International Research Laboratory of Carbon-Based FunctionalMaterials and Devices
  • Suzhou Key Laboratory of Nanotechnology and Biomedicine
  • Higher Education Discipline Innovation Project

Zitieren

APA

Liu, X., Zhao, Z., Li, W., Ren, M., Zhang, H., Cao, D., Wang, Y., Yang, H., Li, Y., Zhu, M., Xie, L., & Yin, L. (2025). Rationally Engineering Pro‐Proteins and Membrane‐Penetrating α‑Helical Polypeptides for Genome Editing Toward Choroidal Neovascularization Treatment. Advanced Materials. https://doi.org/10.1002/adma.202412366

Vancouver

Liu X, Zhao Z, Li W, Ren M, Zhang H, Cao D, et al. Rationally Engineering Pro‐Proteins and Membrane‐Penetrating α‑Helical Polypeptides for Genome Editing Toward Choroidal Neovascularization Treatment. Advanced Materials. 2025. doi:10.1002/adma.202412366

BibTeX
@article{Liu2025,
  author = {Liu, Xun and Zhao, Ziyin and Li, Wei and Ren, Mengyao and Zhang, Haoyu and Cao, Desheng and Wang, Yehan and Yang, He and Li, Yajie and Zhu, Manhui and Xie, Laiqing and Yin, Lichen},
  title = {Rationally Engineering Pro‐Proteins and Membrane‐Penetrating α‑Helical Polypeptides for Genome Editing Toward Choroidal Neovascularization Treatment},
  journal = {Advanced Materials},
  year = {2025},
  doi = {10.1002/adma.202412366}
}
Kostenlos starten →